| Special population considerations and regulatory affairs for clinical research KN Grimsrud, CMT Sherwin, JE Constance, C Tak, AF Zuppa, ... Clinical research and regulatory affairs 32 (2), 45-54, 2015 | 54 | 2015 |
| Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications C Stockmann, JE Constance, JK Roberts, J Olson, EH Doby, K Ampofo, ... Clinical pharmacokinetics 53, 429-454, 2014 | 54 | 2014 |
| Targeting malignant mitochondria with therapeutic peptides JE Constance, CS Lim Therapeutic delivery 3 (8), 961-979, 2012 | 54 | 2012 |
| Considerations in the pharmacologic treatment and prevention of neonatal sepsis C Stockmann, MG Spigarelli, SC Campbell, JE Constance, JD Courter, ... Pediatric Drugs 16, 67-81, 2014 | 51 | 2014 |
| Herbal medicines: challenges in the modern world. Part 4. Canada and United States KM Job, TKL Kiang, JE Constance, CMT Sherwin, EY Enioutina Expert review of clinical pharmacology 9 (12), 1597-1609, 2016 | 49 | 2016 |
| Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants JK Roberts, C Stockmann, JE Constance, J Stiers, MG Spigarelli, ... Clinical pharmacokinetics 53, 581-610, 2014 | 46 | 2014 |
| Direct induction of apoptosis using an optimal mitochondrially targeted p53 M Mossalam, KJ Matissek, A Okal, JE Constance, CS Lim Molecular pharmaceutics 9 (5), 1449-1458, 2012 | 44 | 2012 |
| Xenobiotic metabolism of plant secondary compounds in juniper (Juniperus monosperma) by specialist and generalist woodrat herbivores, genus Neotoma SL Haley, JG Lamb, MR Franklin, JE Constance, MD Dearing Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology …, 2007 | 41 | 2007 |
| A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates JE Constance, AH Balch, C Stockmann, MW Linakis, EK Korgenski, ... Archives of Disease in Childhood-Fetal and Neonatal Edition 101 (3), F236-F243, 2016 | 40 | 2016 |
| Controlling subcellular localization to alter function: Sending oncogenic Bcr–Abl to the nucleus causes apoptosis AS Dixon, M Kakar, KMH Schneider, JE Constance, BC Paullin, CS Lim Journal of controlled release 140 (3), 245-249, 2009 | 39 | 2009 |
| Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis AS Dixon, GD Miller, BJ Bruno, JE Constance, DW Woessner, TP Fidler, ... Molecular pharmaceutics 9 (1), 187-195, 2012 | 34 | 2012 |
| Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections KM Job, J Olson, C Stockmann, JE Constance, EY Enioutina, JE Rower, ... Expert review of anti-infective therapy 14 (8), 731-746, 2016 | 29 | 2016 |
| Pediatric vancomycin dosing: trends over time and the impact of therapeutic drug monitoring AH Balch, JE Constance, EA Thorell, C Stockmann, EK Korgenski, ... The Journal of Clinical Pharmacology 55 (2), 212-220, 2015 | 27 | 2015 |
| Xenobiotic Metabolism of Plant Secondary Compounds in Oak (Quercus Agrifolia) by Specialist and Generalist Woodrat Herbivores, Genus Neotoma SL Haley, JG Lamb, MR Franklin, JE Constance, MD Dearing Journal of chemical ecology 33, 2111-2122, 2007 | 27 | 2007 |
| “Pharm-ecology” of diet shifting: biotransformation of plant secondary compounds in creosote (Larrea tridentata) by a woodrat herbivore, Neotoma lepida SL Haley, JG Lamb, MR Franklin, JE Constance, MD Dearing Physiological and Biochemical Zoology 81 (5), 584-593, 2008 | 25 | 2008 |
| Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs AS Dixon, JE Constance, T Tanaka, TH Rabbitts, CS Lim Pharmaceutical research 29, 1098-1109, 2012 | 24 | 2012 |
| Characteristics and publication patterns of obstetric studies registered in ClinicalTrials. gov C Stockmann, CMT Sherwin, G Koren, SC Campbell, JE Constance, ... The Journal of Clinical Pharmacology 54 (4), 432-437, 2014 | 21 | 2014 |
| Pharmacokinetics, pharmacodynamics and pharmacogenetics associated with nonsteroidal anti-inflammatory drugs and opioids in pediatric cancer patients JE Constance, SC Campbell, AA Somani, V Yellepeddi, KH Owens, ... Expert Opinion on Drug Metabolism & Toxicology 13 (7), 715-724, 2017 | 18 | 2017 |
| Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib JE Constance, DW Woessner, KJ Matissek, M Mossalam, CS Lim Molecular pharmaceutics 9 (11), 3318-3329, 2012 | 18 | 2012 |
| Selective targeting of c-Abl via a cryptic mitochondrial targeting signal activated by cellular redox status in leukemic and breast cancer cells JE Constance, SD Despres, A Nishida, CS Lim Pharmaceutical research 29, 2317-2328, 2012 | 18 | 2012 |
